Department of Surgery and Transplantation, University of Zurich, Zurich, Switzerland.
Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
Ann Surg. 2024 Nov 1;280(5):763-771. doi: 10.1097/SLA.0000000000006471. Epub 2024 Aug 5.
To provide improved guidance for the consistent application of the Clavien-Dindo classification (CDC) and Comprehensive Complication Index (CCI ® ) in challenging clinical scenarios.
Standardized outcome reporting is key for the proper assessment of surgical procedures. A recent consensus conference recommended the CDC and the CCI ® for assessing postoperative morbidity. Several challenging scenarios for grading complications still require evidence-based guidance, and the use of the 2 metrics in randomized controlled trials (RCTs) remains unexplored.
We assessed the use of the CDC and CCI ® as an outcome measure in a systematic literature search. In addition, we asked 163 international surgeons to critically evaluate and independently grade complications in 20 complex clinical scenarios. Finally, a Core Group of 5 experts used this information to develop consistent recommendations.
Until July 2023, 1327 RCTs selected the CDC and/or CCI ® to assess morbidity. Annual use was steadily increasing with now over 200 new RCTs per year. However, only a third (n = 335) of published RCTs provided the complete range of CDC grades, including all subgrades. Eighty-nine out of 163 surgeons (response rate: 55%) completed the questionnaire that served as a basis for the recommendations: repetitive interventions that are required to treat one complication, complications followed by further complications, complications occurring before referral, and expected and unrelated complications to the original procedure should all be counted separately and included in the CCI ® . Invasive blank diagnostic interventions should not be considered a complication.
The increasing use of the CDC and CCI ® in RCTs highlights the importance of their standardized application. The current consensus on various difficult scenarios may offer novel guidance for the consistent use of the CDC and CCI ® , aiming to improve complication reporting and better quality control, ultimately benefiting all health care stakeholders and, first and foremost, all patients.
为一致应用 Clavien-Dindo 分类(CDC)和综合并发症指数(CCI®)于挑战性临床情况提供改进的指导。
标准化结果报告是评估手术程序的关键。最近的共识会议建议使用 CDC 和 CCI®来评估术后发病率。对于分级并发症,仍有几个具有挑战性的情况需要循证指导,并且这两个指标在随机对照试验(RCT)中的应用仍未得到探索。
我们在系统文献检索中评估了 CDC 和 CCI®作为结局测量的使用。此外,我们要求 163 名国际外科医生批判性地评估并独立分级 20 个复杂临床情况的并发症。最后,一个由 5 名专家组成的核心小组使用这些信息制定一致的建议。
截至 2023 年 7 月,1327 项 RCT 选择了 CDC 和/或 CCI®来评估发病率。每年的使用量稳步增加,现在每年有超过 200 项新的 RCT。然而,只有三分之一(n=335)的已发表 RCT 提供了完整的 CDC 分级范围,包括所有亚分级。163 名外科医生中有 89 名(回应率:55%)完成了问卷调查,该问卷为建议提供了依据:需要重复干预以治疗一种并发症、并发症后进一步并发症、在转诊前发生的并发症、以及与原始手术无关的预期并发症,均应单独计数并纳入 CCI®。侵入性空白诊断干预不应被视为一种并发症。
RCT 中 CDC 和 CCI®的使用日益增加,强调了其标准化应用的重要性。目前对于各种困难情况的共识可能为 CDC 和 CCI®的一致应用提供新的指导,旨在改善并发症报告和更好的质量控制,最终使所有医疗保健利益相关者受益,首先也是最重要的是所有患者受益。